Gen9 Launches Rationally Designed DNA Variant Libraries
July 31, 2014
CAMBRIDGE, Massachusetts — — Gen9, Inc., a pioneer in the development of scalable technologies for synthesizing and assembling DNA, today announced the launch of its Variant Libraries product, which allows customers to test virtually any number of DNA variant combinations and examine structure-function relationships. Initial applications include antibody or peptide engineering, and later versions of [...]
TRANSGENOMIC ANNOUNCES ISSUANCE OF NEW EUROPEAN PATENT COVERING COLD-PCR TECHNOLOGIES
July 31, 2014
OMAHA, Neb. -- Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that the European Patent Office has issued a new patent, European Patent No. 21833798, covering one of its COLD-PCR family of DNA amplification technologies. [...]
Analytical Systems Int’l. KECO Announces Release of New Process Analyzer
July 31, 2014
Houston, TX -- Analytical Systems Int'l. KECO, a Houston-based gas refining, manufacturing and transporting processes analysis firm, recently released the205 H2S in Crude Oil Analyzer, a process analyzer that will quantify the amount of Hydrogen Sulfide (H2S) content in crude oil and other liquids. Safely storing and transporting sour crude oil and condensate via roadways, [...]
BIONANO GENOMICS ANNOUNCES THE PURCHASE OF THE IRYS SYSTEM BY BGI
July 31, 2014
SAN DIEGO and SHENZHEN, China -- BioNano Genomics announced today the purchase of an Irys™System by BGI, the world's largest genomics organization. BGI selected BioNano's platform to enable comprehensive exploration of human structural variation (SV) and to provide vastly improved assemblies for various organisms of interest, including those where no reference exists. In addition, BioNano [...]
July 31, 2014
NEW YORK, NY -- Enzo Biochem, Inc. (NYSE:ENZ) announced today that Thomas C. Wright, MD, a leading authority in Women’s Health Diagnostics, has joined the Company as a Consulting Pathologist and Medical Advisor to the Company’s Women’s Health Initiative. Dr. Wright is a leading expert in gynecological pathology in the U.S. He was the Director [...]
ZEISS Introduces LSM 880 with Airyscan
July 31, 2014
JENA/Germany -- Today, ZEISS is introducing LSM 880 with Airyscan. The new confocal laser scanning microscope offers high sensitivity, enhanced resolution in x, y and z, and high image-acquisition speed in one system. Sensitivity, Resolution, and Speed Surveys results reveal that confocal imaging would benefit the most from increased sensitivity, resolution, and speed. Airyscan extends [...]
Rand Capital Announces Net Asset Value of $4.43, Two New Investments and Five Follow-On Investments
July 31, 2014
BUFFALO, N.Y. -- Rand Capital Corporation ("Rand") (Nasdaq:RAND) announced June 30, 2014 net asset value of $28.4 million, or $4.43 per share, representing a $.08 increase per share from March 31, 2014, and a $.50 per share increase from June 30, 2013. Portfolio activity during the second quarter of 2014 included: Empire Genomics, LLC (Buffalo, [...]
AB SCIEX Announces the 4500MD Series* for In Vitro Diagnostic Use
July 31, 2014
FRAMINGHAM, Mass.-- AB SCIEX, a global leader in analytical technologies, today confirmed its commitment to support the diagnostic market with the unveiling of the Triple Quad™ 4500MD and QTRAP® 4500MD LC/MS/MS systems under its SCIEX Diagnostics brand. Expected to be available in the US and select EU countries in September, the 4500MD series joins the [...]
Illumina, Inc. has added a news release to its Investor Relations website.
July 31, 2014
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced that Jeff Huber has joined the company's Board of Directors. Mr. Huber is Senior Vice President at Google Inc. where he works at Google[x]. Mr. Huber joined Google in 2003 and led development for Google Maps (2011-2013), Google Apps (2005-2010), and Google Ads (2003-2011). Prior to Google, [...]
July 31, 2014
LONDON -- The UK is set to become the world leader in ground-breaking genetic research into cancer and rare diseases, which will transform how diseases are diagnosed and treated, thanks to a package of investment worth more than £300million, the Prime Minister will announce today. The four year project will allow scientists to do pioneering [...]

